359 related articles for article (PubMed ID: 16469459)
1. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.
Kocbek P; Baumgartner S; Kristl J
Int J Pharm; 2006 Apr; 312(1-2):179-86. PubMed ID: 16469459
[TBL] [Abstract][Full Text] [Related]
2. Preparation and characterization of freeze-dried 2-methoxyestradiol nanoparticle powders.
Du B; Li XT; Zhao Y; A YM; Zhang ZZ
Pharmazie; 2010 Jul; 65(7):471-6. PubMed ID: 20662313
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions.
Verma S; Gokhale R; Burgess DJ
Int J Pharm; 2009 Oct; 380(1-2):216-22. PubMed ID: 19596059
[TBL] [Abstract][Full Text] [Related]
4. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.
Lai F; Sinico C; Ennas G; Marongiu F; Marongiu G; Fadda AM
Int J Pharm; 2009 May; 373(1-2):124-32. PubMed ID: 19429297
[TBL] [Abstract][Full Text] [Related]
5. [Development of Silymarin nanocrystals lyophilized power applying nanosuspension technology].
Zhao X; Wang G; Zhang B; Li H; Nie Q; Zang C; Zhao X
Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(12):1503-8. PubMed ID: 19777833
[TBL] [Abstract][Full Text] [Related]
6. Nanosuspensions: a promising formulation for the new phospholipase A2 inhibitor PX-18.
Pardeike J; Müller RH
Int J Pharm; 2010 May; 391(1-2):322-9. PubMed ID: 20214969
[TBL] [Abstract][Full Text] [Related]
7. Solution calorimetry as an alternative approach for dissolution testing of nanosuspensions.
Kayaert P; Li B; Jimidar I; Rombaut P; Ahssini F; Van den Mooter G
Eur J Pharm Biopharm; 2010 Nov; 76(3):507-13. PubMed ID: 20887787
[TBL] [Abstract][Full Text] [Related]
8. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
Liu P; Rong X; Laru J; van Veen B; Kiesvaara J; Hirvonen J; Laaksonen T; Peltonen L
Int J Pharm; 2011 Jun; 411(1-2):215-22. PubMed ID: 21458552
[TBL] [Abstract][Full Text] [Related]
9. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs.
Kassem MA; Abdel Rahman AA; Ghorab MM; Ahmed MB; Khalil RM
Int J Pharm; 2007 Aug; 340(1-2):126-33. PubMed ID: 17600645
[TBL] [Abstract][Full Text] [Related]
10. Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres.
Quintanar-Guerrero D; Tamayo-Esquivel D; Ganem-Quintanar A; Allémann E; Doelker E
Eur J Pharm Sci; 2005 Oct; 26(2):211-8. PubMed ID: 16046105
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine.
Hecq J; Deleers M; Fanara D; Vranckx H; Amighi K
Int J Pharm; 2005 Aug; 299(1-2):167-77. PubMed ID: 15996838
[TBL] [Abstract][Full Text] [Related]
12. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
[TBL] [Abstract][Full Text] [Related]
13. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
Xia D; Quan P; Piao H; Piao H; Sun S; Yin Y; Cui F
Eur J Pharm Sci; 2010 Jul; 40(4):325-34. PubMed ID: 20417274
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous formation of drug-containing acrylic nanoparticles.
Bodmeier R; Chen H; Tyle P; Jarosz P
J Microencapsul; 1991; 8(2):161-70. PubMed ID: 1765898
[TBL] [Abstract][Full Text] [Related]
15. Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam.
Ambrus R; Kocbek P; Kristl J; Sibanc R; Rajkó R; Szabó-Révész P
Int J Pharm; 2009 Nov; 381(2):153-9. PubMed ID: 19616609
[TBL] [Abstract][Full Text] [Related]
16. Advantages of celecoxib nanosuspension formulation and transformation into tablets.
Dolenc A; Kristl J; Baumgartner S; Planinsek O
Int J Pharm; 2009 Jul; 376(1-2):204-12. PubMed ID: 19426794
[TBL] [Abstract][Full Text] [Related]
17. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
18. Drug release and permeation studies of nanosuspensions based on solidified reverse micellar solutions (SRMS).
Friedrich I; Reichl S; Müller-Goymann CC
Int J Pharm; 2005 Nov; 305(1-2):167-75. PubMed ID: 16242276
[TBL] [Abstract][Full Text] [Related]
19. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility.
Mou D; Chen H; Wan J; Xu H; Yang X
Int J Pharm; 2011 Jul; 413(1-2):237-44. PubMed ID: 21540090
[TBL] [Abstract][Full Text] [Related]
20. Preparation of a chemically stable quercetin formulation using nanosuspension technology.
Gao L; Liu G; Wang X; Liu F; Xu Y; Ma J
Int J Pharm; 2011 Feb; 404(1-2):231-7. PubMed ID: 21093559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]